1. Home
  2. ORIS vs ACTU Comparison

ORIS vs ACTU Comparison

Compare ORIS & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIS
  • ACTU
  • Stock Information
  • Founded
  • ORIS 2014
  • ACTU 2015
  • Country
  • ORIS China
  • ACTU United States
  • Employees
  • ORIS N/A
  • ACTU N/A
  • Industry
  • ORIS Farming/Seeds/Milling
  • ACTU
  • Sector
  • ORIS Consumer Staples
  • ACTU
  • Exchange
  • ORIS Nasdaq
  • ACTU NYSE
  • Market Cap
  • ORIS 182.0M
  • ACTU 153.1M
  • IPO Year
  • ORIS 2024
  • ACTU 2024
  • Fundamental
  • Price
  • ORIS $1.41
  • ACTU $6.74
  • Analyst Decision
  • ORIS
  • ACTU
  • Analyst Count
  • ORIS 0
  • ACTU 0
  • Target Price
  • ORIS N/A
  • ACTU N/A
  • AVG Volume (30 Days)
  • ORIS 2.6M
  • ACTU 73.4K
  • Earning Date
  • ORIS 12-31-2024
  • ACTU 11-13-2024
  • Dividend Yield
  • ORIS N/A
  • ACTU N/A
  • EPS Growth
  • ORIS N/A
  • ACTU N/A
  • EPS
  • ORIS 0.96
  • ACTU N/A
  • Revenue
  • ORIS $24,122,000.00
  • ACTU N/A
  • Revenue This Year
  • ORIS N/A
  • ACTU N/A
  • Revenue Next Year
  • ORIS N/A
  • ACTU N/A
  • P/E Ratio
  • ORIS $1.47
  • ACTU N/A
  • Revenue Growth
  • ORIS N/A
  • ACTU N/A
  • 52 Week Low
  • ORIS $1.22
  • ACTU $5.51
  • 52 Week High
  • ORIS $56.01
  • ACTU $10.16
  • Technical
  • Relative Strength Index (RSI)
  • ORIS N/A
  • ACTU N/A
  • Support Level
  • ORIS N/A
  • ACTU N/A
  • Resistance Level
  • ORIS N/A
  • ACTU N/A
  • Average True Range (ATR)
  • ORIS 0.00
  • ACTU 0.00
  • MACD
  • ORIS 0.00
  • ACTU 0.00
  • Stochastic Oscillator
  • ORIS 0.00
  • ACTU 0.00

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: